About Us  |  Contact Us  |  Español
Butler Hospital
Butler Hospital

Testosterone Antidepressant Augmentation Research Study

Enrolling Adult Women in a Testosterone Antidepressant Augmentation Clinical Trial for Major Depressive Disorder

Butler Hospital's  Mood Disorders Research Program (MDRP) is currently enrolling women with major depressive disorder, ages 21-65, in a new research clinical trial. The study investigates the use of low-dose testosterone cream (applied to skin daily as an "add-on" treatment) when a woman's depression medications have not produced full relief from symptoms.

  • Study participants will be randomly assigned to receive an active or placebo cream, while continuing on a stable dose of a their primary antidepressants.
  • The study involves 6 visits to the MDRP research clinic on the Butler Hospital campus over an 8-week period. Limited transportation support is provided.

Eligibility

Adult women with major depressive disorder, ages 21-65.

If you are interested in learning more about the Testosterone Antidepressant Augmentation research study, please call (401) 455-6537 or fill out the following form: 

Please provide your name, telephone number, and a good time to reach you in the boxes below.  Please do not include any other information.  When you are done, press submit. A member of the research team will contact you soon.


Your Name:
Telephone Number:
Best time to be reached:
(Please specify am or pm)
Health Headlines
Two Drugs Work Equally Well for Epileptic Seizures in Kids: StudyView in a lightbox
For Teen Drivers, Unruly Passengers May Be Greater Threat Than PhonesView in a lightbox
Glaucoma Drug May Help Reverse Obesity-Related Vision LossView in a lightbox
Certain Type of Brain Malformation May Be Best Left AloneView in a lightbox
Could Cow Fertilizer Help Spread Antibiotic Resistance?View in a lightbox
Butler Hospital
© 2011 Site Index | Disclaimer | Legal Notices